Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Do not call
En
Medicamen Organics Ltd. Share Price
Day's Range
Low
₹23.65
High
₹23.65
Price Summary
| Previous Close | ₹23.65 |
|---|---|
| Day's Range | ₹23.65 - ₹23.65 |
| Open | ₹23.65 |
| 52 Week Range | ₹19.10 - ₹32.00 |
| Volume | 10,000 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2.37 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -2.70 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 1.17 |
| PAT Margin (%) | -17.76 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -10.38 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 370.88 |
| Expenses | N/A | N/A |
| PBT | N/A | 43.87 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 32.71 |
About Medicamen Organics Ltd.
| Founded | 1995 |
|---|---|
| Managing Director | Bal Kishan Gupta |
| NSE Symbol | MEDIORG |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,54,913.91 | 1,888.30 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 3,00,380.35 | 11,425.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,81,169.21 | 4,693.00 | 3,672.30 - 3,672.30 |
| Laurus Labs Ltd. | 1,31,566.03 | 2,396.70 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,25,837.35 | 728.80 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,23,511.02 | 8,509.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,18,712.93 | 1,199.50 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,14,933.37 | 1,380.70 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,14,477.74 | 1,403.50 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,09,746.08 | 2,639.10 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Sigachi Industries informs about monitoring agency report
Godavari Drugs informs about newspaper advertisement
Sai Life Sciences informs about monitoring agency report
Pursuant to Regulation 30 and 32 of SEBI Listing Regulations, Sai Life Sciences informed that it enclosed the report of Monitoring Agency for the quarter ended 30th September 2026, issued by CRISIL Ratings Limited in relation to the utilisation of proceeds raised through the Company's Initial Public Offer (IPO).
Vineet Laboratories informs about newspaper advertisement
Vineet Laboratories has informed that it enclosed clippings of the Newspaper Advertisement published in the newspapers, Financial Express (English) and Nava Telangana (Telugu) on 11.11.2026 for notice of convening 10th Annual General Meeting of the company for the financial year 2025-26. The newspaper publications are also made available on its website at the following https://vineetlabs.co.in.
The above information is a part of company’s filings submitted to BSE.
Zydus Lifesciences informs about update on investment
In its intimation dated June 26, 2026, the Company had informed about execution of Share Subscription and Shareholders’ Agreement (‘SSSHA’) with Sunshine Healthcare Lanka (‘Sunshine’) and Zydus Sunshine Lifesciences (‘Zydus Sunshine’) to subscribe 50% of the total paid-up equity share capital of Zydus Sunshine (‘Subscription Shares’). It was also informed that post subscription of the Subscription Shares, Zydus Sunshine shall become a 50:50 joint venture of Zydus and Sunshine. It was stated therein that the transaction of subscription of Subscription Shares and joint venture were expected to be completed within 90 working days. Vide letter dated October 1, 2026, the Company informed that the Company and Zydus Sunshine mutually agreed to extend the closing date and the transactions are expected to be completed by December 2026. Zydus Lifesciences has that the above transaction of subscription of Subscription Shares and joint venture are completed on November 11, 2026. Due to office holidays during the festive season, there was a delay in sending the intimation.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Medicamen Organics Ltd. is ₹23.65 as of 2026-11-12.
The market capitalisation of Medicamen Organics Ltd. is ₹36.68 as of 2026-11-11.
The 1-year return of Medicamen Organics Ltd. is -3.95% as of 2026-11-12.
The P/E ratio of Medicamen Organics Ltd. is 0.00 as of 2026-11-12.
The 52-week high and low of Medicamen Organics Ltd. are ₹32.00 and ₹19.10, respectively, as of 2026-11-12.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
